Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148

ClinicalTrials.gov ID: NCT02317549

Public ClinicalTrials.gov record NCT02317549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 (SSAIL Trial)

Study identification

NCT ID
NCT02317549
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Leading BioSciences, Inc
Industry
Enrollment
8 participants

Conditions and interventions

Conditions

Interventions

  • LB1148 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2015
Primary completion
Feb 29, 2016
Completion
Feb 29, 2016
Last update posted
May 31, 2020

2015 – 2016

United States locations

U.S. sites
26
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Providence Hospital Mobile Alabama 36608
Community Regional Medical Center, Fresno Fresno California 93721
Long Beach Memorial Medical Center Long Beach California 90806
UC Davis Medical Center Sacramento California 95817
OSF Saint Francis Medical Center Peoria Illinois 61637
University of Iowa Iowa City Iowa 52242
University of Kansas Medical Center Kansas City Kansas 66160
ARH Regional Medical Center Hazard Kentucky 41701
University of Louisville Hospital Laboratory Louisville Kentucky 40202
Lahey Hospital and Medical Center Burlington Massachusetts 01805
Baystate Medical Center Springfield Massachusetts 01199
University of Michigan Health Center Ann Arbor Michigan 48109
Henry Ford Hospital Detroit Michigan 48202
Mayo Clinic Labs - Rochester Campus Rochester Minnesota 55905
Barnes Jewish Hospital St Louis Missouri 63110
St. Patrick Hospital Missoula Montana 59802
Cooper University Hospital Camden New Jersey 08103
New York Methodist Hospital Brooklyn New York 11215
UNC Chapel Hill Chapel Hill North Carolina 27599
Wake Forest Baptist Health Winston-Salem North Carolina 27157
Mercy St. Vincent Medical Center, Clinical Research Offices Toledo Ohio 43608
OU Medical Center Oklahoma City Oklahoma 73104
Vanderbilt University Medical Center Nashville Tennessee 37232
Ben Taub Hospital Houston Texas 77030
University of Virginia Health System Charlottesville Virginia 22908
Froedtert Hospital and Medial College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02317549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 31, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02317549 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →